Try
Celltrion, Inc
068270.KSSouth Korea
62 filed reports · 943 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
62 reports · Mar 2011 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Half Year · 11012DART | 16 | 7,395 | Jun 2011 to Jun 2026 |
| Q1 · 11013DART | 16 | 6,653 | Mar 2011 to Mar 2026 |
| Annual · 11011DART | 15 | 5,830 | Dec 2011 to Dec 2025 |
| Q3 · 11014DART | 15 | 6,845 | Sep 2011 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 H1 | 11012 | Jun 30, 2026 | Aug 14, 2026 | 882 | Open |
| FY2026 Q1 | 11013 | Mar 31, 2026 | May 15, 2026 | 791 | Open |
| FY2025 | 11011 | Dec 31, 2025 | Mar 16, 2026 | 973 | Open |
| FY2025 Q3 | 11014 | Sep 30, 2025 | Nov 14, 2025 | 894 | Open |
| FY2025 H1 | 11012 | Jun 30, 2025 | Aug 14, 2025 | 639 | Open |
| FY2025 Q1 | 11013 | Mar 31, 2025 | May 15, 2025 | 646 | Open |
| FY2024 | 11011 | Dec 31, 2024 | Mar 17, 2025 | 676 | Open |
| FY2024 Q3 | 11014 | Sep 30, 2024 | Nov 14, 2024 | 720 | Open |
| FY2024 H1 | 11012 | Jun 30, 2024 | Aug 14, 2024 | 762 | Open |
| FY2024 Q1 | 11013 | Mar 31, 2024 | May 16, 2024 | 655 | Open |
| FY2023 | 11011 | Dec 31, 2023 | Mar 18, 2024 | 1,002 | Open |
| FY2023 Q3 | 11014 | Sep 30, 2023 | Nov 14, 2023 | 460 | Open |
Financial data
943 concepts · 26,723 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS928 concepts · 25,699 facts · Mar 2010 to Jun 2026
- Cost of Revenue223 · Mar 2010 to Jun 2026
- EPS (Basic)223 · Mar 2010 to Jun 2026
- EPS (Diluted)223 · Mar 2010 to Jun 2026
- Finance Income223 · Mar 2010 to Jun 2026
- Gross Profit223 · Mar 2010 to Jun 2026
- Income Tax Expense (Benefit)223 · Mar 2010 to Jun 2026
- Net Income223 · Mar 2010 to Jun 2026
- Operating Income223 · Mar 2010 to Jun 2026
- Pretax Income223 · Mar 2010 to Jun 2026
- Revenue223 · Mar 2010 to Jun 2026
- Other Comprehensive Income221 · Mar 2010 to Jun 2026
- Stockholders Equity217 · Mar 2010 to Jun 2026
- Cash and Equivalents214 · Mar 2010 to Jun 2026
- Current Tax Liabilities211 · Dec 2010 to Jun 2026
- Elements of other stockholder's equity211 · Dec 2010 to Jun 2026
- Inventory211 · Dec 2010 to Jun 2026
- Issued Share Capital211 · Dec 2010 to Jun 2026
- Retained Earnings (Accumulated Deficit)211 · Dec 2010 to Jun 2026
- Total Assets211 · Dec 2010 to Jun 2026
- Total Current Assets211 · Dec 2010 to Jun 2026
- Total Current Liabilities211 · Dec 2010 to Jun 2026
- Total Equity and Liabilities211 · Dec 2010 to Jun 2026
- Total Liabilities211 · Dec 2010 to Jun 2026
- Total Noncurrent Assets211 · Dec 2010 to Jun 2026
Segment15 concepts · 1,024 facts · Dec 2022 to Jun 2026
- Revenue304 · Dec 2022 to Jun 2026
- Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts179 · Dec 2022 to Jun 2026
- Internal revenue92 · Mar 2023 to Sep 2025
- Depreciation expense91 · Dec 2022 to Jun 2026
- Operating Income91 · Dec 2022 to Jun 2026
- Amortisation expense73 · Dec 2022 to Dec 2025
- Net revenue56 · Dec 2023 to Sep 2025
- Total revenue36 · Mar 2023 to Sep 2024
- Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contract28 · Sep 2024 to Mar 2026
- Net Revenue24 · Jun 2023 to Sep 2024
- Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contract14 · Jun 2025 to Jun 2026
- Amortisation Expense of Intangible Assets10 · Jun 2025 to Jun 2026
- Amortisation expense(segments)10 · Mar 2025 to Mar 2026
- Internal Sales8 · Dec 2022 to Dec 2023
- Sales total8 · Dec 2022 to Dec 2023
Segments
1,024 factsFigures broken down by business line, region, product or another axis the company reports on.
Geographical areas37 members · 513 facts
- CountryOfDomicileMember109 · Dec 2022 to Jun 2026
- ForeignCountriesMember40 · Dec 2022 to Mar 2026
- EliminationOfIntersegmentAmountsMember32 · Dec 2022 to Sep 2024
- AsiaOfGeographicalAreasMemberOfDisclosureOfGeographicalAreasTableOfMember30 · Dec 2023 to Mar 2026
- CentralAndSouthAmericaOfGeographicalAreasMemberOfDisclosureOfGeographicalAreasTableOfMember30 · Dec 2023 to Mar 2026
- EuropeOfGeographicalAreasMemberOfDisclosureOfGeographicalAreasTableOfMember30 · Dec 2023 to Mar 2026
- NorthAmericaOfGeographicalAreasMemberOfDisclosureOfGeographicalAreasTableOfMember30 · Dec 2023 to Mar 2026
- AsiaOfGeographicalAreasMemberOfTwoRegionalRevenueTableOfMember24 · Mar 2023 to Sep 2024
- EuropeOfGeographicalAreasMemberOfTwoRegionalRevenueTableOfMember24 · Mar 2023 to Sep 2024
- LatinAmericaOfGeographicalAreasMemberOfTwoRegionalRevenueTableOfMember24 · Mar 2023 to Sep 2024
- NorthAmericaOfGeographicalAreasMemberOfTwoRegionalRevenueTableOfMember24 · Mar 2023 to Sep 2024
- AsiaOfGeographicalAreasMemberOfNonCurrentAssetsByRegionTableOfMember9 · Dec 2023 to Dec 2025
- EuropeOfGeographicalAreasMemberOfNonCurrentAssetsByRegionTableOfMember9 · Dec 2023 to Dec 2025
- NorthAmericaOfGeographicalAreasMemberOfNonCurrentAssetsByRegionTableOfMember9 · Dec 2023 to Dec 2025
- SouthEastAmericaOfGeographicalAreasMemberOfNonCurrentAssetsByRegionTableOfMember9 · Dec 2023 to Dec 2025
- AsiaMember8 · Jun 2025 to Jun 2026
- AsiaOfGeographicalAreasMemberOfTwoRegionalSalesBasedOnLocationTableOfMember8 · Dec 2022 to Dec 2023
- DomesticOfGeographicalAreasMemberOfTwoRegionalSalesBasedOnLocationTableOfMember8 · Dec 2022 to Dec 2023
- EuropeMember8 · Jun 2025 to Jun 2026
- NorthAmericaMember8 · Jun 2025 to Jun 2026
- AmericasOfGeographicalAreasMemberOfTwoRegionalSalesBasedOnLocationTableOfMember6 · Dec 2022 to Dec 2023
- MiddlesouthAmericaMemberOfGeographicalAreasDomainOfDisclosureOfGeographicalAreasTableOfMember4 · Jun 2025 to Jun 2026
- AsiaMemberOfGeographicalAreasMemberOfDisclosureOfNetSalesByGeographicalAreaTableOfMember2 · Mar 2025 to Mar 2026
- AsiaMemberOfGeographicalAreasMemberOfNonCurrentAssetsExcludingFinancialInstrumentsDeferredTaxAssetsRetirementBenefitAssetsAndRightsArisingFromInsuranceContractsTableOfMember2 · Mar 2025 to Mar 2026
- CentralAndSouthAmericaMemberOfGeographicalAreasMemberOfDisclosureOfNetSalesByGeographicalAreaTableOfMember2 · Mar 2025 to Mar 2026
- CentralAndSouthAmericaMemberOfGeographicalAreasMemberOfNonCurrentAssetsExcludingFinancialInstrumentsDeferredTaxAssetsRetirementBenefitAssetsAndRightsArisingFromInsuranceContractsTableOfMember2 · Mar 2025 to Mar 2026
- DomesticGeographicalMemberOfGeographicalAreasMemberOfRevenuePerGeographicalMarketTableOfMember2 · Mar 2025 to Mar 2026
- EroupeOfGeographicalAreasMemberOfThreeNonCurrentAssetForTheLocationTableOfMember2 · Dec 2022 to Dec 2023
- EuropeMemberOfGeographicalAreasMemberOfDisclosureOfNetSalesByGeographicalAreaTableOfMember2 · Mar 2025 to Mar 2026
- EuropeMemberOfGeographicalAreasMemberOfNonCurrentAssetsExcludingFinancialInstrumentsDeferredTaxAssetsRetirementBenefitAssetsAndRightsArisingFromInsuranceContractsTableOfMember2 · Mar 2025 to Mar 2026
- MiddlesouthAmericaMemberOfGeographicalAreasDomainOfDisclosureOfNetSalesByGeographicalAreaTableOfMember2 · Jun 2025 to Jun 2026
- MiddlesouthAmericaMemberOfGeographicalAreasDomainOfNonCurrentAssetsExcludingFinancialInstrumentsDeferredTaxAssetsRetirementBenefitAssetsAndRightsArisingFromInsuranceContractsTableOfMember2 · Jun 2025 to Jun 2026
- NorthAmericaMemberOfGeographicalAreasMemberOfDisclosureOfNetSalesByGeographicalAreaTableOfMember2 · Mar 2025 to Mar 2026
- NorthAmericaMemberOfGeographicalAreasMemberOfNonCurrentAssetsExcludingFinancialInstrumentsDeferredTaxAssetsRetirementBenefitAssetsAndRightsArisingFromInsuranceContractsTableOfMember2 · Mar 2025 to Mar 2026
- NorthAmericaOfGeographicalAreasMemberOfThreeNonCurrentAssetForTheLocationTableOfMember2 · Dec 2022 to Dec 2023
- OceaniaOfGeographicalAreasMemberOfThreeNonCurrentAssetForTheLocationTableOfMember2 · Dec 2022 to Dec 2023
- SouthAmericaOfGeographicalAreasMemberOfThreeNonCurrentAssetForTheLocationTableOfMember2 · Dec 2022 to Dec 2023
Segment consolidation items6 members · 261 facts
- EliminationOfIntersegmentAmountsMember79 · Dec 2023 to Jun 2026
- OperatingSegmentsMember60 · Dec 2023 to Jun 2026
- AllOtherSegmentsMember40 · Dec 2023 to Sep 2025
- BiopharmaceuticalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember40 · Dec 2023 to Sep 2025
- ChemicalMedicinesOfOperatingSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember40 · Dec 2023 to Sep 2025
- MaterialReconcilingItemsMember2 · Jun 2025 to Jun 2026
Products and services8 members · 160 facts
- EliminationOfIntersegmentAmountsMember40 · Dec 2022 to Sep 2024
- BiopharmaceuticalMedicinesOfProductsAndServicesMemberOfOneSegmentInformationTableOfMember38 · Dec 2022 to Sep 2024
- ChemicalMedicinesOfProductsAndServicesMemberOfOneSegmentInformationTableOfMember38 · Dec 2022 to Sep 2024
- udf_NOTE_2024515145540645Member28 · Mar 2023 to Sep 2024
- OthersOfProductsAndServicesMemberOfOneSegmentInformationTableOfMember10 · Dec 2022 to Dec 2023
- ChemicalMedicinesOfProductsAndServicesMemberOfNonCurrentAssetsBySegmentTableOfMember2 · Mar 2023 to Mar 2024
- Eight54PmKyungtaeKimBiopharmaceuticalMedicinesOfProductsAndServicesMemberOfNonCurrentAssetsBySegmentTableOfMember2 · Mar 2023 to Mar 2024
- OthersOfProductsAndServicesMemberOfNonCurrentAssetsBySegmentTableOfMember2 · Mar 2023 to Mar 2024
Segments7 members · 90 facts
- AllOtherSegmentsMember30 · Dec 2024 to Jun 2026
- BiopharmaceuticalMedicinesMemberOfSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember10 · Mar 2025 to Mar 2026
- BiopharmaceuticalMedicinesOfReportableSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember10 · Dec 2024 to Dec 2025
- BiopharmaceuticalProductsMemberOfSegmentsDomainOfDisclosureOfOperatingSegmentsTableOfMember10 · Jun 2025 to Jun 2026
- ChemicalMedicinesMemberOfSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember10 · Mar 2025 to Mar 2026
- ChemicalMedicinesOfReportableSegmentsMemberOfDisclosureOfOperatingSegmentsTableOfMember10 · Dec 2024 to Dec 2025
- ChemicalPharmaceuticalProductsMemberOfSegmentsDomainOfDisclosureOfOperatingSegmentsTableOfMember10 · Jun 2025 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.